15 16 17 2 SUMMARY 1 Gene expression can be post-transcriptionally regulated via dynamic and reversible 2 RNA modifications. N 1 -methyladenosine (m 1 A) is a recently identified mRNA 3 modification; however, little is known about its precise location, regulation and 4 function. Here, we develop a base-resolution m 1 A profiling method, based on m 1 A-5 induced misincorporation during reverse transcription, and report distinct classes of 6 m 1 A methylome in the human transcriptome. m 1 A in 5'-UTR, particularly those at the 7 first nucleotide of mRNA, associate with increased translation efficiency. A different 8 subset of m 1 A exhibit a GUUCRA tRNA-like motif, are evenly distributed in the 9 transcriptome and are dependent on the methyltransferase TRMT6/61A. Additionally, 10 we show for the first time that m 1 A is prevalent in the mitochondrial-encoded 11 transcripts. Manipulation of m 1 A level via TRMT61B, a mitochondria-localizing m 1 A 12 methyltransferase, demonstrates that m 1 A in mitochondrial mRNA interferes with 13 translation. Collectively, our approaches reveal distinct classes of m 1 A methylome 14 and provide a resource for functional studies of m 1 A-mediated epitranscriptomic 15 regulation. 16 17 3
INTRODUCTION 1
More than 100 different types of post-transcriptional modifications have been 2 identified so far (Machnicka et al., 2013) . Recent breakthroughs in sequencing 3 technologies have greatly advanced our understanding to the location, regulation, RESULTS 1 m 1 A-induced misincorporation during reverse transcription 2 Because m 1 A can cause both truncation and misincorporation during cDNA 3 synthesis (Hauenschild et al., 2015; Zubradt et al., 2017) , we first established the 4 truncation and mutation profiles of different reserve transcriptases (RTases). We 5 systematically compared the performance of several commercially available RTases 6 (including AMV, SuperScript II, SuperScript III and TGIRT) under different conditions 7 ( Figure S1 ). We found that m 1 A can precisely induce misincorporation at the site of 8 modification, while m 1 A-induced truncation is less accurate and can occur to the 9 neighboring nucleotides. In addition, the truncation profile could be complicated by 10 RNA secondary structures and the fragmentation process needed for library 11 preparation. We concluded that the mutation profile contains a higher signal/noise 12 ratio and is more precise in detecting the exact position of m 1 A. Among the RTases 13 we tested, TGIRT demonstrated excellent read-through efficiency and relatively high 14 mutation frequency at the site of m 1 A ( Figure S1B ), consistent with the recent MaPseq and DM-tRNA-seq results (Zheng et al., 2015; Zubradt et al., 2017) . 16 Moreover, we employed a ligation-based strand-specific library preparation protocol 17 (Van Nostrand et al., 2016) , which ensures that the m 1 A-induced mutation is within 18 the sequenced fragment (see Method Details). 19 Because we only observed ~40-50% mutation rate at m 1 A1322 in 28S rRNA 20 ( Figure S2A ), which is known to be of high modification level, we further examined 21 6 the quantitative capability of TGIRT. We chemically synthesized two model RNA 1 sequences with site-specific m 1 A modification. For m 1 A sites with ~97-98% 2 modification level (measured by quantitative mass spectrometry) ( Figure S2B) , we 3 consistently observed ~66-75% misincorporation ( Figure S2C) ; the mismatch rate 4 dropped non-linearly when we gradually lowered the modification level. Even with 5 ~50% m 1 A modification, a mismatch rate of only ~9-10% was observed ( Figure   6 S2C). These findings suggest that the observed mutation rate is an underestimation 7 of the actual modification level. While the TGIRT-based procedure can still detect 8 m 1 A sites of high modification level, sequencing RNA directly with TGIRT may not be 9 able to capture the m 1 A sites with averaging modification level in the transcriptome 10 (~20% as previously measured by microarray) (Dominissini et al., 2016) . To improve 11 the sensitivity for transcriptome-wide m 1 A detection, we decided to couple the 12 TGIRT-based procedure with a pre-enrichment step and an additional in vitro 13 demethylation step ( Figure 1A) . We first show that in vitro demethylation reaction 14 mediated by the demethylase AlkB is more efficient than the Dimroth reaction, 15 demonstrating ~98% and ~80% efficiency ( Figure S2D ), respectively. In addition, the 16 extended treatment of RNA in alkaline condition during the Dimroth reaction leads to 17 excessive RNA degradation ( Figure S2E ), potentially causing loss of RNA molecules. 18 By integrating the enrichment and demethylation steps, we successfully maximized 19 the dynamic range of m 1 A-induced mutational signature for m 1 A1322 in 28S rRNA 20 (~47%, ~95% and ~0.9% in the input, (-) and (+) demethylase samples, 21 respectively), allowing sensitive and confident m 1 A detection ( Figure 1B ). We termed 22 7 our approach misincorporation-assisted profiling of m 1 A, or m 1 A-MAP. 1 2 m 1 A-MAP detects known and novel m 1 A in tRNA 3 We next applied m 1 A-MAP to tRNA. In mammals, m 1 A can occur at position 9, 14 4 and 58 of tRNA (Anderson and Droogmans, 2005) . m 1 A14 has been reported only in 5 tRNA Phe and is considered to be very rare (Machnicka et al., 2013) ; we did not 6 observe any m 1 A modification at position 14 for cytosolic tRNAs in HEK293T cells 7 (Table S1 ). m 1 A58 is conserved across the three domains of life; previous tRNA 8 microarray and sequencing data has reported hypomodified tRNAs at this position 9 (Cozen et al., 2015; Saikia et al., 2010; Zheng et al., 2015) . Our results confirmed 10 that m 1 A58 is globally present in the cytosolic tRNAs ( Figure 1C and S2F). The m 1 A9 11 modification exists only in archaea tRNA or mammalian mitochondrial tRNA; 12 interestingly, we observed a novel m 1 A9 site for cytosolic tRNA Asp(GUC) , representing 13 the first cytosolic tRNA with m 1 A modification at position 9 ( Figure 1D ). Collectively, 14 these observations suggest that m 1 A-MAP is highly sensitive in detecting m 1 A at 15 single-base resolution.
17
Single-nucleotide resolution m 1 A methylome in the transcriptome 18 We then sought to detect transcriptome-wide m 1 A methylome at single-base 19 resolution. We defined two parameters to evaluate the m 1 A-MAP data: difference of 20 mismatch rate and fold change of mismatch rate (see Method Details). To minimize 21 8 the effect of mismatch rate variation during m 1 A identification, we rigorously tested 1 our threshold and identified 740 m 1 A sites in the 293T transcriptome (Table S1 -3). To 2 evaluate potential false positives caused by m 1 A-independent mismatch, we 3 performed the opposite calculation and retrieved only 17 such sites (see Method   4 Details). Moreover, we also systematically evaluated the mutation pattern of the 5 identified m 1 A sites in the transcriptome. Using m 1 A sites in tRNA as positive 6 controls, we found that m 1 A-induced mutation is more strongly influenced by its 5'-7 nucleotide than the 3'-nucleotide; importantly, a similar sequence-dependent feature 8 is also observed for m 1 A sites in mRNA (Figure 2A and S3A). Therefore, we 9 conclude that our strict threshold allowed us to confidently detect transcriptome-wide 10 m 1 A sites at single-nucleotide resolution.
11
Out of the 740 m 1 A modifications in the transcriptome ( Figure S3B ), 473 sites are 12 located in mRNA and lncRNA molecules ( Figure S3C and Table S2 ). Majority of 13 these sites are within the 5'-UTR ( Figure 2B and 2C), consistent with the previous 14 finding ( Dominissini et al., 2016; Li et al., 2016a) . Our single-base profile also reveals 15 new features of the m 1 A methylome: for instance, we found 24 m 1 A methylation sites 16 that are present exactly at the first nucleotide of the 5' end of the transcripts ( Figure   17 2D and Table S2 ). Because the first two nucleotides of the 5' end of mRNA are 18 known to contain ribose methylation, it is likely that these transcripts have an m 1 Am 19 modification at the cap+1 site. We also found 3 additional transcripts with m 1 A 20 methylation at the second nucleotide, potentially giving rise to m 1 Am at cap+2 as 21 well. For m 1 A located in CDS, while we did not observe a tendency for codon 22 position, we did notice a mild preference for codon types, with Arg(CGA) being the 1 most frequently modified by m 1 A ( Figure S3D ). No m 1 A is detected for AUG start found that these two positions belong to annotated SNP sites, demonstrating the 7 robustness of our approach in distinguishing true m 1 A sites from false signals (SNP, 8 other modifications and etc.).
9
Because m 1 A is enriched in the 5'-UTR, we examined whether m 1 A could be 10 involved in translation regulation. We performed ribosome profiling and compared 11 the translation efficiency for transcripts with or without m 1 A. We found that m 1 A within 12 the 5'-UTR positively correlates with the translation efficiency of mRNA ( Figure 2G ).
13
This positive correlation is even stronger for m 1 A at the cap+1 position, but is not 14 observed for m 1 A located in CDS nor 3'-UTR. This observation hints that m 1 A within 15 different regions of mRNA may have different biological functions. An unbiased motif detection using DREME revealed that a subset of m 1 A (53 sites) 19 are found within a strong GUUCRA sequence ( Figure 3A) . Interestingly, these sites 20 demonstrate a very different distribution pattern: instead of being enriched in the 5'-21 UTR, these sites are evenly distributed in the transcriptome ( Figure 3B ). Because 22 this motif is reminiscent of the m 1 A-containing TΨC loop in tRNA, we hypothesized 1 that the tRNA methyltransferase complex TRMT6/61A could be responsible for these 2 mRNA m 1 A sites. We first performed direct m 1 A sequencing (without antibody 3 enrichment) to RNA population below 200nt. We found that the m 1 A58 sites within 4 the GUUCNA motif experienced a global decrease of mutation rate in the 5 TRMT6/61A knock-down sample, which was not observed for m 1 A58 sites that do 6 not confine to the motif ( Figure 3C , S4A and S4B). This result suggests that 7 TRMT6/61A-mediated m 1 A methylation is highly sequence-specific, consistent with 8 evidence from crystal structures (Finer-Moore et al., 2015) . We then analyzed the 9 secondary structure for the 53 mRNA m 1 A sites, and found highly conserved 10 structural features compared to the T-loop of tRNA ( Figure S4C and S4D). We also 11 picked 3 m 1 A sites (in CDS, 3'-UTR and lncRNA, respectively) and examined their 12 response after TRMT6/61A knock-down ( Figure 3D ). Our locus-specific approach 13 (see Method Details), which enabled us to interrogate these sites with high 14 sequencing depth, unambiguously demonstrated a decrease in mismatch rate after 15 TRMT6/61A knock-down ( Figure 3D ). As a comparison, a non-motif m 1 A site located 16 in a different structural context demonstrated an unaltered modification status 17 ( Figure 3E ). Taken together, these observations suggest that in addition to tRNA, 18 TRMT6/61A is also responsible for a subset of m 1 A sites in mRNA.
20
Distinct m 1 A methylome in the mitochondrial transcriptome 21 In addition to the nuclear-encoded transcripts, we also detected prevalent m 1 A 22 modification in the mitochondrial (mt) transcriptome. mt-tRNAs are known to contain 1 m 1 A at position 9 and 58 (Suzuki et al., 2011) , catalyzed by TRMT10C and 2 TRMT61B (Chujo and Suzuki, 2012; Vilardo et al., 2012) , respectively. m 1 A-MAP 3 showed that all the 14 mt-tRNAs bearing an adenosine residue at position 9 are m 1 A 4 modified; for position 58, m 1 A was detected for the 3 known and 2 novel mt-tRNA 5 molecules ( Figure 4 and Table S3 ). For mt-rRNA, the only known m 1 A site is at 6 position 947 of 16S rRNA (Bar-Yaacov et al., 2016) . Interestingly, we additionally 7 detected 7 and 10 novel m 1 A sites on 16S and 12S mt-rRNA, respectively ( Figure 4 8 and Table S3 ). This is very different from cytosolic rRNA, where there is only one 9 m 1 A site in 28S rRNA (m 1 A1322). Considering the length of these rRNA species, mt-10 rRNAs are much more heavily modified by m 1 A.
11
In human mitochondria, mRNAs are transcribed from the heavy and light strands 12 as polycistronic units (Falkenberg et al., 2007; Mercer et al., 2011) . The processed 13 mt-mRNAs lack a cap at the 5' end and contain no or short untranslated regions 14 (Richter-Dennerlein et al., 2015; Rorbach and Minczuk, 2012; Temperley et al., 15 2010). We identified 22 m 1 A sites from 10/13 mitochondrial genes, in which 21 are 16 residing in CDS and 1 is located in the 3'-UTR ( Figure 4 ). This is distinct to the m 1 A 17 methylome in the nuclear-encoded transcripts, where m 1 A is enriched in the 5'-UTR.
18
In addition, no preference for codon types was observed, yet m 1 A appears to be 19 more likely present at the third position of a codon in the CDS of mt-mRNA ( Figure   20 S5A). Moreover, we also identified 25 m 1 A sites within the intergenic spacers. 24/25 21 m 1 A sites are in the light strand ( Figure 4B ); some of these m 1 A sites could be within 22 the 3'-UTR of MT-ND6, for which there is no current consensus of its 3' end 1 (Slomovic et al., 2005) .
2 3 m 1 A in mt-mRNA interferes with mitochondrial translation 4 We next sought to examine the biological consequence of m 1 A in the mt-mRNAs.
5
Translation requires accurate base pairing between mRNA codons and the cognate 6 tRNAs; however, m 1 A is known to block the canonical A:U base pairing. These facts 7 prompted us to hypothesize that m 1 A in mt-mRNA, which are primarily located in 8 CDS, could interfere with translation in mitochondria. We first integrated published 9 mitochondria ribosome profiling data with m 1 A-MAP identified m 1 A methylome in Because TRMT10C is a subunit of the mitochondrial RNase P complex and is not 20 specific for adenosine, we focused on TRMT61B. We utilized a qPCR-based assay 21 to quantitatively evaluate the modification status of the m 1 A sites in mt-mRNAs (see 22 1 level ( Figure S5C and S5D), TRMT61B overexpression greatly increased the m 1 A 2 modification level of several mt-mRNAs ( Figure 5B and S5D). This observation 3 suggests that in addition to mt-tRNA and mt-rRNA, TRMT61B could also target mt-4 mRNA. Because of the high efficiency of TRMT61B overexpression in increasing the 5 m 1 A level, we used mass spectrometry to quantitatively measure the mitochondrial 6 protein level upon TRMT61B overexpression ( Figure S5E ). Indeed, TRMT61B 7 overexpression led to a reduced protein level for MT-CO2 and MT-CO3 ( Figure 5C 8 and S5F), which are targets of TRMT61B. We further confirmed this observation for 9 the MT-CO2 protein using Western blot ( Figure 5D ). Collectively, these results 10 suggest that m 1 A in mt-mRNA interferes with translation in mitochondria. In this study, we developed a single-nucleotide resolution method for transcriptome-14 wide identification of m 1 A in human cells. m 1 A-MAP utilizes the m 1 A-induced 15 misincorporation in cDNA synthesis to achieve base-resolution m 1 A detection. This 16 enabled us to identify m 1 A modification not only at the mRNA cap, but also within a 17 GUUCRA tRNA-like sequence motif. In principle, such misincorporation-dependent 18 strategy could be applied to estimate the modification status of RNA sites of interest. ). Hence, while direct sequencing (without enrichment) could still detect m 1 A 3 sites with high modification level, m 1 A sites with averaging modification level or those 4 located within a non-optimal context for mismatch induction could be missed.
Therefore, coupling the pre-enrichment step to the mutational signature is necessary 6 to improve the detection sensitivity. In addition, to achieve high confidence, we 7 employed an in vitro demethylation step, which enabled us to distinguish true m 1 A 8 sites from false signals (SNP, other modifications, and etc.) in the transcriptome. The 9 combined use of mutational signature, the pre-enrichment step and the in vitro 10 demethylation step enabled m 1 A-MAP to achieve high sensitivity and confidence.
11
Our study revealed that two known m 1 A modification machinery, TRMT6/61A and 12 TRMT61B, could work on mRNA as well. The hetero complex TRMT6/61A 13 recognizes the sequence and structure of the tRNA T-loop and installs an m 1 A at the 14 58 position (Finer-Moore et al., 2015) . Consistent with this knowledge, we found that 15 the TRMT6/61A-dependent mRNA m 1 A sites are also confined to a hairpin structure 16 mostly frequently with a 7nt loop, reminiscent of the tRNA T-loop. In contrast, we did 17 not find an obvious sequence context for the m 1 A in mt-mRNA. In fact, TRMT61B 18 appears to be a promiscuous enzyme that also modifies mt-tRNA and mt-rRNA; the 19 substrate specificity and the underlying mechanism of TRMT61B in the human 20 mitochondria remains to be determined. In addition, the fact that both TRMT6/61A Our results also revealed m 1 A in mt-mRNA for the first time and showed that 1 such methylation interferes with translation. By manipulating the m 1 A level via 2 TRMT61B, we monitored the corresponding changes of the mitochondrial protein Conversely, because16S rRNA and mt-tRNA Leu(UUR) are already of high m 1 A level, we 10 envisioned that TRMT61B overexpression should lead to a greater increase of m 1 A 11 level in mRNA than in these ncRNAs. In this simplified scenario, we indeed observed 12 greatly increased modification level for the mt-mRNA and detected reduced protein 13 level for two mitochondrial proteins, whose mRNA transcripts are m 1 A modified. shown to enhance translation in mitochondria (Zhang et al., 2014) . We analyzed the 4 published CLASH results in which microRNA and their direct mRNA targets are 5 captured (Helwak et al., 2013) ; interestingly, we found two m 1 A sites that are located 6 within the experimentally verified targets of microRNA ( Figure S5G ). In fact, these 7 m 1 A sites reside exactly within mRNA sequences that form base-pairing with the 8 seed regions of microRNAs. More m 1 A sites in mt-mRNA were found within the 9 predicted mt-mRNA targets of the microRNA seed regions ( Figure S5H ). While both 10 the speculated mechanisms point to a suppressive role of m 1 A in mitochondria 11 translation, alternative hypothesis and mechanism should also be tested in future 12 experiments. Nevertheless, our discovery that m 1 A in mt-mRNA interferes with 13 translation improves our understanding of translation regulation in human 14 mitochondria.
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RNA isolation 12
Total RNA was isolated from cells using TRIzol, according to the manufacturer's instructions 13 (Invitrogen). An additional DNaseI treatment step was performed to avoid DNA contamination. 14 For polyA  RNA isolation, small RNA was depleted first using MEGAclear™ Transcription Clean-15
Up Kit (Ambion), followed by two successive rounds of polyA  selection using oligo(dT)25 16 dynabeads (Invitrogen). For small RNA isolation, RNA smaller than 200 nt were recovered from 17 the flow-through fraction in the small RNA depletion step by ethanol precipitation. C for 6 h, followed by the addition of 2.5 μL 0.5 M MES buffer, pH 6.5 and 0.5 U alkaline 1 phosphatase (Sigma, P4252). The mixture was incubated at 37 C for another 6 h and diluted to 2 50 μL. 5 μL of the solution was injected into LC-MS/MS. The nucleosides were separated by 3 ultra-performance liquid chromatography on a C18 column, and then detected by triple- The m 1 A RNA oligoes and A RNA oligoes were mixed at the ratio: 100%, 75%, 50%, 25%, 17 12.5%, 6.25% and 0%, respectively. The mixed m 1 A /A oligoes were subjected to library 18 construction using specific RT primers as listed: 19
RT-m 1 A /A-1: ACACGACGCTCTTCCGATCTagcggcctgaaagaggc; 20
RT-m 1 A /A-2: ACACGACGCTCTTCCGATCTggggagccggggcc. 21 26 1
Cloning, Expression and Purification of AlkB 2
A truncated AlkB with deletion of the N-terminal 11 amino acids was cloned into pET30a 3 (Novagen) and transformed to E. coli BL21(DE3) followed by growing in LB medium at 37 C 4 until the OD600 reached 0.6-0.8 and incubating at 30 C for additional 4 h with the addition of 1 5 mM IPTG. Proteins were purified using Ni-NTA chromatography (GE Healthcare) and gel-6 filtration chromatography (Superdex 200, GE Healthcare) followed by Mono-Q anion exchange 7 chromatography (GE Healthcare). Such purification procedure effectively avoided RNA 8 contamination from E coli. (expression host). 9 10
In vitro Demethylation treatment 11
In vitro demethylation treatment mediated by the demethylase AlkB: 10 μg full length polyA  RNA 12 was fragmented at 95 C for 5 min using magnesium RNA fragmentation buffer (NEB) and 13 fragmented polyA  RNA was desalted and concentrated by ethanol precipitation. 10 μg (~0.2 14 nmol) fragmented polyA  RNA was denatured at 65 C for 5 min, and then demethylated in a 500 15 μL demethylation mixture containing 0.4 nmol purified AlkB, 50 mM MES, pH 6.5, 283 μM of 16 (NH4)2Fe(SO4)2· 6H2O, 300 µM 2-ketoglutarate, 2 mM L-ascorbic acid, 1 U/μL SUPERaseIn 17
RNase Inhibitor (Invitrogen). The demethylation reaction was incubated for 2 h at 37 C and 18
quenched by the addition of 5 mM EDTA. The demethylated RNA was then purified by phenol 19 chloroform extraction. 2 Plates of 15-cm HEK293T cells were grown to 90% confluency; CHX was then added to the 17 medium at a final concentration of 100 μg/mL for 7 min. The cells were then harvested and lysed 18 with 1 mL lysis buffer (10 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 100 mM KCl, 1% Triton X-100, 2 19 mM DTT, 100 μg/mL CHX, 0.5 U/μL RNase inhibitor, 1×complete protease inhibitor). The cell 20 lysates were centrifuged at 15,000g for 15 min and the supernatant was collected followed by 1 measuring the OD260 of cell lysates. 100 μL lysates were kept as input sample and 1 mL TRIzol 2 was added to purify the RNA. 1 μL Micrococcal Nuclease (NEB) per 25OD was added to the 3 remaining cell lysates and allowed to incubate at 25 °C for 20 min. The digested cell lysates were 4 used for performing ribosome foot-printing. Lysates were fractioned on 10/50% w/v sucrose 5 gradients using the SW-40Ti rotor at 27,500rpm for 4h. 80S monosome fractions were collected 6 followed by the addition of equal volume of extraction buffer (1% SDS, 40 mM EDTA). RNA was 7 isolated by phenol-chloroform extraction. RNA fragments between 28-30 nt were selected using 8 15% Urea-PAGE. Recovered RNA fragments were subjected to library construction. In brief, 9
RNA samples were dephosphorylated with PNK (NEB) and ligated to 3' RP linker (5'rAPP-10 CTGTAGGCACCATCAAT-3SpC3) using T4 RNA ligase2, truncated KQ (NEB). Reverse 11 transcription was carried using Superscript III (Invitrogen) with RP-RT primer (5Phos-12 AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGC-SpC18-CACTCA-13
SpC18-TTCAGACGTGTGCTCTTCCGATCTATTGATGGTGCCTACAG). cDNA was circ-ligated 14 with CircLigase II (Epicentre) and then amplified by PCR with primers (5-15 AATGATACGGCGACCACCGAGATCTACAC-3'; 5'-16 CAAGCAGAAGACGGCATACGAGATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGA 17 TC-3', XXXXXX represents index sequence). PCR products were purified by 8% TBE gel and 18 sequenced on Illumina Hiseq 2500 with single end reads (50 bp). 19 20 qPCR-based m 1 A level evaluation 21 32 20 μg polyA  RNA was isolated from HEK293T cells with TRMT61B overexpression, knock-down 1 and the corresponding mock controls, respectively. RNA was fragmented into ~150 nt using 2 magnesium RNA fragmentation buffer (NEB) and concentrated by ethanol precipitation. 3
Fragmented RNA (as input) was denatured and incubated with 2 μg anti-m 1 A antibody in IPP 4 buffer (150 mM NaCl, 0.1% NP-40, 10 mM Tris, pH 7.4) at 4°C overnight. 20 μL Protein A/G 5 UltraLink Resin (Pierce) was added to the RNA antibody mixture and incubated for additional 3 h 6 at 4°C . Resins were washed with twice with IPP buffer, once with low salt buffer (75 mM NaCl, 7 0.1% NP-40, 10 mM Tris, pH 7.4), once with high salt buffer (200 mM NaCl, 0.1% NP-40, 10 mM 8
Tris, pH 7.4) and twice with TEN buffer (10 mM Tris, pH 7.4, 1 mM EDTA, pH 8.0, 0.05% NP-40). 9 m 1 A-containing RNA was eluted from resins with 3 mg/mL N 1 -methyladenosine 10 (Berry&Associates) in IPP buffer and purified by phenol chloroform extraction and ethanol 11 precipitation. Input and immunoprecipitated RNAs were reverse transcribed into cDNA using 12 Superscript III (Invitrogen) and quantified by qPCR using SYBR GREEN mix (Takara) on Roche 13
Lightcycler 96 real-time PCR system. The m 1 A-IP/input ratio of target regions in the TRMT61B 14 overexpression, knock-down and the corresponding control samples were calculated, Mitochondria was isolated from TRMT61B overexpression and mock control HEK293T cell lines 9 according to the manufacturer's (Thermo Fisher) and lysed with RIPA buffer followed by 10 sonication. After extraction, total proteins from different cell lines were quantified with the BCA 11 protein assay kit (Thermo Fisher). Equal amount of proteins from two cell lines were digested by 12 trypsin on-column in 100 mM TEAB buffer and subjected to reductive dimethylation labeling. 4 μL 13 of 4% (w/w) light or heavy formaldehyde was added to 100 μL of trypsin digested samples 14 prepared from TRMT61B overexpression and mock control HEK293T cells, respectively. In the 15 meantime, 4 μL of 0.6 M sodium cyanoborohydride was added and the samples were incubated 16 at room temperature for 1h. The dimethylation labeling reaction was quenched by the addition of 17 1% (w/w) ammonia and 5% (w/w) formic acid. Finally, light and heavy labeled peptide samples 18 were mixed, concentrated by vacuum, and analyzed on a Q Exactive mass spectrometer 19
